chronic cognitive impairment improved after eculizumab initiation in cases of nmosd
Published 2 years ago • 140 plays • Length 2:50Download video MP4
Download video MP3
Similar videos
-
10:36
spheres: collecting real-world data to explore disease characteristics & clinical outcomes in nmosd
-
4:56
eculizumab: a review in neuromyelitis optica spectrum disorder
-
3:00
unmet needs in the diagnostics and treatment of nmosd
-
5:27
prospects for improving cognitive impairment in early ms with ozanimod
-
20:19
nmosd multidisciplinary approach webinar, 25 june 2021 - dr. suzan ibrahim noori
-
6:18
soliris® (eculizumab) mechanism of action for neuromyelitis optica spectrum disorder (nmosd)
-
2:18
predictors of early serologic diagnosis of aq4-igg positive nmosd
-
1:27:16
nmosd unveiled: optimizing long-term outcomes in neuromyelitis optica spectrum disorder with inno...
-
6:47
retinal atrophy independent of optic neuritis in aqp4 nmosd
-
5:44
diagnostic criteria and treatment updates for nmosd
-
1:46
alzheimer's disease research priorities: disease modification and symptom management
-
3:49
cognitive and neuropsychiatric effects of noradrenergic treatment in alzheimer’s disease
-
1:10:51
asymptomatic neurocognitive impairment in people living with hiv (...) - hiv & aging 2023
-
2:43
new, relatively cheap potential treatment for alzheimer’s disease
-
7:42
matsuda's neuroimaging complete#004 「dopaminergic spect in movement disorders」
-
2:24
is amyloid lowering still a valid approach in alzheimer’s disease?
-
4:09
non-pharmacological management of neuropsychiatric symptoms in dementia
-
11:43
cerebral oxygenation during exercise deteriorates with advancing chronic kidney disease
-
20:23
prognostication in neurocritical care with dr. susanne muehlschlegel